Related Experiment Video
Updated: Aug 26, 2025

A Simple Composite Phenotype Scoring System for Evaluating Mouse Models of Cerebellar Ataxia
Published on: May 21, 2010
Overview of the Clinical Approach to Individuals With Cerebellar Ataxia and Neuropathy
Leslie J Roberts1, Michael McVeigh1, Linda Seiderer1
1Neurophysiology Department (L.J.R.,L.S.), Department of Neurology & Neurological Research, St Vincent's Hospital; Department of Medicine (L.J.R., L.S.), the University of Melbourne; Ballance Disorders and Ataxia Service (L.J.R., M.M., D.J.S.), Eye and Ear Hospital; Department of Neuroscience (I.H.H., L.A.C.), Central Clinical School, Monash University; Monash Biomedical Imaging (I.H.H., L.A.C.), Monash University; Bruce Lefroy Centre (L.A.C.), Murdoch Children's Research Institute; 7Department of Paediatrics, Melbourne University; Turner Institute for Brain and Mental Health, Monash University; Victorian Clinical Genetics Services (M.D.), Murdoch Children's Reseach Institute; and The Florey Institute of Neuroscience and Mental Health (D.J.S.), the University of Melbourne, Australia.
Abstract:
Increasingly, cerebellar syndromes are recognized as affecting multiple systems. Extracerebellar features include peripheral neuropathies affecting proprioception; cranial neuropathies such as auditory and vestibular; and neuronopathies, for example, dorsal root and vestibular. The presence of such features, which in and of themselves may cause ataxia, likely contribute to key disabilities such as gait instability and falls. Based on the evolving available literature and experience, we outline a clinical approach to the diagnosis of adult-onset ataxia where a combination of cerebellar and peripheral or cranial nerve pathology exists. Objective diagnostic modalities including electrophysiology, oculomotor, and vestibular function testing are invaluable in accurately defining an individual's phenotype. Advances in MRI techniques have led to an increased recognition of disease-specific patterns of cerebellar pathology, including those conditions where neuronopathies may be involved. Depending on availability, a stepwise approach to genetic testing is suggested. This is guided by factors such as pattern of inheritance and age at disease onset, and genetic testing may range from specific genetic panels through to whole-exome and whole-genome sequencing. Management is best performed with the involvement of a multidisciplinary team, aiming at minimization of complications such as falls and aspiration pneumonia and maximizing functional status.
Related Concept Videos
Parkinson's Disease: Overview
Major Somatic Sensory Pathways
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...

